Camtek director sells 5,532 shares up to $172.74

Q: What transactions did CAMT director Andorn Karni Yarl report on this Form 4?

The Form 4 reports option exercises and related share sales in August 2026. Options for 4,056 Ordinary Shares were exercised, and 5,532 shares were sold in several open-market transactions at prices above the respective exercise prices.

Q: How many CAMT shares did Andorn Karni Yarl sell according to this Form 4?

The reporting person sold a total of 5,532 Ordinary Shares. These include 3,176 shares at $164.40, 880 shares at $172.7428, and 1,476 shares at a weighted average price of $172.1221 per share.

Q: At what prices were CAMT stock options exercised in this filing?

Stock options were exercised for 3,176 shares at an exercise price of $22.63 per share and for 880 shares at an exercise price of $63.51 per share. The resulting Ordinary Shares were then sold in separate market transactions.

Q: Were the CAMT options and underlying shares exercised and sold on the same dates?

Yes. A footnote states that the options were exercised and the underlying shares were sold on the same date as reported. This applies to the option exercises for 3,176 shares and 880 shares reported in the Form 4.

Q: What does the weighted average price disclosure mean in the CAMT Form 4?

For the sale of 1,476 shares, the Form 4 reports a weighted average price of $172.1221, with individual trades ranging from $172.1094 to $172.1571. The reporting person offers to provide full trade-by-trade details upon request.

Q: Does the CAMT Form 4 indicate a net buying or selling position by the insider?

The transaction summary shows a net-sell position of 5,532 shares. While options for 4,056 shares were exercised, all resulting shares were sold, leading to overall net share dispositions in the reported period.

CAMTEK LTD director Andorn Karni Yarl reported option exercises and share sales in August 2026.

Filing Impact

(High)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

CAMTEK LTD director Andorn Karni Yarl reported option exercises and share sales in August 2026. On August 14, stock options for 3,176 Ordinary Shares at an exercise price of $22.63 per share were exercised and the resulting shares were sold at $164.40 per share. On August 13, options for 880 shares at $63.51 were exercised and the resulting shares were sold in multiple transactions, including 880 shares at $172.7428 and 1,476 shares at a weighted average price of $172.1221 per share, with detailed price ranges disclosed in a footnote. The options and underlying shares referenced in certain transactions were exercised and sold on the same dates.

Insights

Analyzing...

Insider Trade Summary

Exercise and sale activity reported; no spread calculated

Exercise and Sale 7 txns

Insider Andorn Karni Yarl

Role Director

Sold 5,532 shs ($928K)

Approx. gross sale proceeds $928K

Approx. exercise cost $128K

Type	Security	Shares	Price	Value
Exercise	Stock Option (Right to Buy) ^F3	3,176	$0.00	$0.00
Exercise	Ordinary Shares ^F1	3,176	$22.63	$72K
Sale	Ordinary Shares	3,176	$164.40	$522K
Exercise	Stock Option (Right to Buy) ^F3	880	$0.00	$0.00
Exercise	Ordinary Shares ^F1	880	$63.51	$56K
Sale	Ordinary Shares	880	$172.7428	$152K
Sale	Ordinary Shares ^F2	1,476	$172.1221	$254K

Holdings After Transaction: Stock Option (Right to Buy) — 0 contracts (Direct); Ordinary Shares — 1,343 shares (Direct)

Footnotes (3)

F1. The shares were acquired upon the exercise of stock options
F2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $172.1094 to $172.1571. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request
F3. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

Key Figures

Shares sold: 5,532 shares Options exercised: 4,056 shares Exercise price: $22.63 per share +4 more

7 metrics

Shares sold 5,532 shares Total Ordinary Shares sold across reported August 2026 transactions

Options exercised 4,056 shares Total underlying shares from option exercises (M transactions)

Exercise price $22.63 per share Stock option for 3,176 shares exercised on 2026-08-14

Exercise price $63.51 per share Stock option for 880 shares exercised on 2026-08-13

Sale price $164.40 per share Sale of 3,176 Ordinary Shares on 2026-08-14

Sale price $172.7428 per share Sale of 880 Ordinary Shares on 2026-08-13

Weighted average sale price $172.1221 per share Weighted average for sale of 1,476 shares, trades from $172.1094 to $172.1571

Key Terms

Stock Option (Right to Buy), derivative security, weighted average price

3 terms

Stock Option (Right to Buy) financial

"security_title is reported as Stock Option (Right to Buy)"

derivative security financial

"transaction_code_description notes Exercise or conversion of derivative security"

A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.

weighted average price financial

"The price reported is a weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transactions did CAMT director Andorn Karni Yarl report on this Form 4?

The Form 4 reports option exercises and related share sales in August 2026. Options for 4,056 Ordinary Shares were exercised, and 5,532 shares were sold in several open-market transactions at prices above the respective exercise prices.

How many CAMT shares did Andorn Karni Yarl sell according to this Form 4?

The reporting person sold a total of 5,532 Ordinary Shares. These include 3,176 shares at $164.40, 880 shares at $172.7428, and 1,476 shares at a weighted average price of $172.1221 per share.

At what prices were CAMT stock options exercised in this filing?

Stock options were exercised for 3,176 shares at an exercise price of $22.63 per share and for 880 shares at an exercise price of $63.51 per share. The resulting Ordinary Shares were then sold in separate market transactions.

Were the CAMT options and underlying shares exercised and sold on the same dates?

Yes. A footnote states that the options were exercised and the underlying shares were sold on the same date as reported. This applies to the option exercises for 3,176 shares and 880 shares reported in the Form 4.

What does the weighted average price disclosure mean in the CAMT Form 4?

For the sale of 1,476 shares, the Form 4 reports a weighted average price of $172.1221, with individual trades ranging from $172.1094 to $172.1571. The reporting person offers to provide full trade-by-trade details upon request.

Does the CAMT Form 4 indicate a net buying or selling position by the insider?

The transaction summary shows a net-sell position of 5,532 shares. While options for 4,056 shares were exercised, all resulting shares were sold, leading to overall net share dispositions in the reported period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Available on EDGAR 08/17/2026 - 08:31 AM Accepted by SEC EDGAR 08/17/2026 - 08:30 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Andorn Karni Yarl

(Last)

(First)

(Middle)

6 ALIYA ST.

(Street)

RAMAT HASHARON

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
CAMTEK LTD [ CAMT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/13/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	08/13/2026		M		880⁽¹⁾	A	$63.51	3,699	D
Ordinary Shares	08/13/2026		S		880	D	$172.7428	2,819	D
Ordinary Shares	08/13/2026		S		1,476	D	$172.1221⁽²⁾	1,343	D
Ordinary Shares	08/14/2026		M		3,176⁽¹⁾	A	$22.63	4,519	D
Ordinary Shares	08/14/2026		S		3,176	D	$164.4	1,343	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Right to Buy)	$63.51	08/13/2026		M⁽³⁾			880	09/25/2024	12/21/2030	Ordinary Shares	880	$0	0	D
Stock Option (Right to Buy)	$22.63	08/14/2026		M⁽³⁾			3,176	12/21/2023	11/10/2029	Ordinary Shares	3,176	$0	0	D

Explanation of Responses:

1. The shares were acquired upon the exercise of stock options

2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $172.1094 to $172.1571. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request

3. The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I.

	/s/ Meirav Shemesh on behalf of Oppenheimer Israel, as Attorney-in-fact	08/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR